logo Anervea.png
A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis - Anervea
17 mars 2024 09h19 HE | ANERVEA DATA LABS PRIVATE LIMITED
Pune, March 17, 2024 (GLOBE NEWSWIRE) -- The recent FDA approval of Resmetirom, developed by Madrigal Pharmaceuticals, has sent ripples of excitement throughout the medical community, marking a...
logo Anervea.png
Revolutionizing Pharma Commercial Analytics: Harnessing the Power of Patient Claims Data - Anervea
29 févr. 2024 03h03 HE | ANERVEA DATA LABS PRIVATE LIMITED
Pune, Feb. 29, 2024 (GLOBE NEWSWIRE) -- In an era where data is pivotal, the pharma industry stands at the cusp of a significant transformation powered by the extensive utilization of patient claims...
Anervea Spearheads Growth in India's Booming Dermatology Market Post-COVID, Aiming to Enhance Pharmaceutical Sales and Marketing Effectiveness
26 févr. 2024 03h30 HE | ANERVEA DATA LABS PRIVATE LIMITED
Anervea, a leading analytics service provider, is at the forefront of transforming the dermatology market landscape in India.